LM Elit, H Hirte - Expert review of anticancer therapy, 2014 - Taylor & Francis
Metastatic or recurrent cervical cancer has a survival duration of approximately 12 months.
Thus, we review the outcomes of chemotherapy and/or novel agents for women who present …